Literature DB >> 29125895

Impact of preserved collateral veins on small-for-size grafts in living donor liver transplantation.

Seong Hoon Kim1, Eung Chang Lee1, Sang Jae Park1.   

Abstract

AIM: Graft size is a critical issue in living donor liver transplantation (LDLT). We hypothesized that too much portal flow could possibly be diverted into pre-existing collateral veins, alleviating small-for-size syndrome (SFSS) in LDLT. This study evaluated the impact of the preserved collateral veins in the outcomes of LDLT using a small-for-size graft.
METHODS: For patient safety, a graft-to-recipient weight ratio (GRWR) <0.8% was strictly confined to patients with collateral veins (group A), and the patient group was compared in a 1:3 ratio to a matched group of patients with GRWR ≥0.8% (group B) using propensity score analysis.
RESULTS: Forty and 120 patients were included in group A and B, respectively. No significant differences in baseline patient characteristics were observed between the two groups except for graft weight and GRWR. The lowest GRWR was 0.4%. The graft portal inflow showed no significant differences for 7 days after graft implantation, ranging from 1668 to 5100 mL/min. Small-for-size syndrome occurred in no patients (0.0%) in group A and in 10 (8.3%) in group B (P = 0.067). Overall survival rates at 1, 3, and 5 years were not different between the two groups (85.0%, 82.5%, and 82.5% vs. 92.5%, 86.7%, and 85.0%, respectively; P = 0.670).
CONCLUSION: Pre-existing collateral veins saved during surgery may have a reserve buffer for excessive portal flow to obviate SFSS in LDLT.
© 2017 The Japan Society of Hepatology.

Entities:  

Keywords:  collateral vein; liver transplantation; portal hyperperfusion; small-for-size graft; small-for-size syndrome

Year:  2017        PMID: 29125895     DOI: 10.1111/hepr.13002

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  2 in total

1.  Survival Analysis after Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single Center Cohort Study.

Authors:  Byung-Gon Na; Seong-Hoon Kim; Sang-Jae Park
Journal:  Biology (Basel)       Date:  2021-05-20

Review 2.  Feasibility of using marginal liver grafts in living donor liver transplantation.

Authors:  Xiang Lan; Hua Zhang; Hong-Yu Li; Ke-Fei Chen; Fei Liu; Yong-Gang Wei; Bo Li
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.